Schnider T W, Minto C F, Shafer S L, Gambus P L, Andresen C, Goodale D B, Youngs E J
Institut für Anästhesie und Intensivbehandlung, Inselspital, Universität Bern, Switzerland.
Anesthesiology. 1999 Jun;90(6):1502-16. doi: 10.1097/00000542-199906000-00003.
The authors studied the influence of age on the pharmacodynamics of propofol, including characterization of the relation between plasma concentration and the time course of drug effect.
The authors evaluated healthy volunteers aged 25-81 yr. A bolus dose (2 mg/kg or 1 mg/kg in persons older than 65 yr) and an infusion (25, 50, 100, or 200 microg x kg(-1) x min(-1)) of the older or the new (containing EDTA) formulation of propofol were given on each of two different study days. The propofol concentration was determined in frequent arterial samples. The electroencephalogram (EEG) was used to measure drug effect. A statistical technique called semilinear canonical correlation was used to select components of the EEG power spectrum that correlated optimally with the effect-site concentration. The effect-site concentration was related to drug effect with a biphasic pharmacodynamic model. The plasma effect-site equilibration rate constant was estimated parametrically. Estimates of this rate constant were validated by comparing the predicted time of peak effect with the time of peak EEG effect. The probability of being asleep, as a function of age, was determined from steady state concentrations after 60 min of propofol infusion.
Twenty-four volunteers completed the study. Three parameters of the biphasic pharmacodynamic model were correlated linearly with age. The plasma effect-site equilibration rate constant was 0.456 min(-1). The predicted time to peak effect after bolus injection ranging was 1.7 min. The time to peak effect assessed visually was 1.6 min (range, 1-2.4 min). The steady state observations showed increasing sensitivity to propofol in elderly patients, with C50 values for loss of consciousness of 2.35, 1.8, and 1.25 microg/ml in volunteers who were 25, 50, and 75 yr old, respectively.
Semilinear canonical correlation defined a new measure of propofol effect on the EEG, the canonical univariate parameter for propofol. Using this parameter, propofol plasma effect-site equilibration is faster than previously reported. This fast onset was confirmed by inspection of the EEG data. Elderly patients are more sensitive to the hypnotic and EEG effects of propofol than are younger persons.
作者研究了年龄对丙泊酚药效学的影响,包括血浆浓度与药物效应时间过程之间关系的特征描述。
作者评估了年龄在25 - 81岁的健康志愿者。在两个不同的研究日,分别给予老年配方或新配方(含乙二胺四乙酸)的丙泊酚单次推注剂量(65岁以上者为1mg/kg,其他为2mg/kg)和输注剂量(25、50、100或200μg·kg⁻¹·min⁻¹)。频繁采集动脉血样测定丙泊酚浓度。采用脑电图(EEG)测量药物效应。使用一种称为半线性典型相关的统计技术来选择与效应室浓度最佳相关的EEG功率谱成分。效应室浓度与药物效应采用双相药效学模型关联。参数估计血浆效应室平衡速率常数。通过比较预测的效应峰值时间与EEG效应峰值时间来验证该速率常数的估计值。根据丙泊酚输注60分钟后的稳态浓度确定入睡概率与年龄的函数关系。
24名志愿者完成了研究。双相药效学模型的三个参数与年龄呈线性相关。血浆效应室平衡速率常数为0.456min⁻¹。推注后预测的效应峰值时间范围为1.7分钟。视觉评估的效应峰值时间为1.6分钟(范围为1 - 2.4分钟)。稳态观察结果显示老年患者对丙泊酚的敏感性增加,25岁、50岁和75岁志愿者意识丧失的C50值分别为2.35、1.8和1.25μg/ml。
半线性典型相关定义了丙泊酚对EEG效应的一种新测量方法,即丙泊酚的典型单变量参数。使用该参数,丙泊酚血浆效应室平衡比先前报道的更快。通过检查EEG数据证实了这种快速起效。老年患者比年轻患者对丙泊酚的催眠和EEG效应更敏感。